Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies with attractive risk-reward profiles. Our valuation framework helps you find stocks with the right balance of growth and value characteristics for your portfolio. We provide P/E analysis, PEG ratios, and relative valuation metrics for comprehensive valuation coverage. Find value in growth with our comprehensive valuation analysis and multiples tools for growth at a reasonable price strategies.
As of 2026-04-20, Tempest Therapeutics Inc. (TPST) trades at a current price of $1.91, marking a 2.55% decline for the current session. This analysis examines near-term technical levels, broader market context for the biotech sector, and potential price scenarios for TPST in upcoming sessions. No recent earnings data is available for the firm as of this writing, so market activity is currently being driven primarily by technical trading patterns and broader sector sentiment, rather than quarterl
Tempest Therapeutics (TPST) Stock: Why Spinoff Value (Tick Down) 2026-04-20 - Rating Change
TPST - Stock Analysis
4787 Comments
1138 Likes
1
Ronald
Engaged Reader
2 hours ago
Free US stock correlation to major indices and sector benchmarks for performance attribution analysis. We help you understand how your portfolio moves relative to broader market benchmarks.
👍 286
Reply
2
Hollie
Returning User
5 hours ago
This feels like something I’ll regret agreeing with.
👍 25
Reply
3
Carlan
Regular Reader
1 day ago
That was ridiculously good. 😂
👍 239
Reply
4
Lynndsey
Registered User
1 day ago
This is truly praiseworthy.
👍 17
Reply
5
Tirrany
Consistent User
2 days ago
Anyone else just stumbled into this?
👍 238
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.